Evidence map›Paper›PMID 33949201›Full record

Trial reportAmerican journal of physiology. Lung cellular and molecular physiology2021

ARDS metabolic fingerprints: characterization, benchmarking, and potential mechanistic interpretation.

Sayed Metwaly, Andréanne Côté, Sarah J Donnelly, Mohammad M Banoei, Chel H Lee, Graciela Andonegui, Bryan G Yipp, Hans J Vogel, Oliver Fiehn, Brent W Winston

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Endotyping in ARDS: one step forward in precision medicine.European journal of medical research · 2024
    Article
  5. Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  10. The Metabolomics of Critical Illness.Handbook of experimental pharmacology · 2023
    Article
  11. Article
  12. Review
  13. Metabolic signatures of ARDS and ARDS heterogeneity.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sayed MetwalySchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0001-5533-6503
Andréanne CôtéInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Montreal, Québec, Canada.
Sarah J DonnellyDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
Mohammad M BanoeiDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
Chel H LeeDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
Graciela AndoneguiDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
Bryan G YippDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-5887-9551
Hans J VogelBio-NMR Center, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Oliver FiehnWest Coast Metabolomics Center, University of California, Davis, California.
Brent W WinstonDepartment of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-2993-8871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aimed to identify acute respiratory distress syndrome (ARDS) metabolic fingerprints in selected patient cohorts and compare the metabolic profiles of direct versus indirect ARDS and hypoinflammatory versus hyperinflammatory ARDS. We hypothesized that the biological and inflammatory processes in ARDS would manifest as unique metabolomic fingerprints that set ARDS apart from other intensive care unit (ICU) conditions and could help examine ARDS subphenotypes and clinical subgroups. Patients with ARDS (

Indexed as

MetabolomeAgedBenchmarkingBiomarkersCase-Control StudiesDiscriminant AnalysisFemaleHumansMaleMiddle AgedRespiratory Distress SyndromeBiomarkersacute respiratory distress syndrome (ARDS)ARDS heterogeneityARDS metabolic fingerprintsARDS metabolomicsARDS subphenotypes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.